| Business Name: |
N Y Glaucoma Institute |
| Contact Person: |
Igor Pankov |
| Address: |
103 Quentin Rd.
G1-1, Brooklyn, New York 11223 |
| Phone Number: |
(718) 645-2201 |
| Website Address: |
glaucomany.com |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2005 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| Share This Business: |
|
| Related Businesses: |
Oleg Katcher Md - Brooklyn, NY 11223
City Wide Health Facility Inc - Brooklyn, NY 11223
Doctor's Office - Brooklyn, NY 11223
Bhayani Rajendra MD - Brooklyn, NY 11223
Fulmes Management Inc - Brooklyn, NY 11223
Nadaf Albert MD - Brooklyn, NY 11223
Vera Kuznetsova Dental Care P C - Brooklyn, NY 11223
Rabin K Rahmani MD - Brooklyn, NY 11223
Rutter Peter L MD - Brooklyn, NY 11223
Nison Badalov MD - Brooklyn, NY 11223
O T Skilled Care Pc - Brooklyn, NY 11223
Gindi Jeffrey MD - Brooklyn, NY 11223
Werrell Albert MD - Brooklyn, NY 11223
Pankova Irina MD - Brooklyn, NY 11223
Family Health Management Inc - Brooklyn, NY 11223
Szilagyi Elizabeth MD - Brooklyn, NY 11223
Levitansky Oksana MD - Brooklyn, NY 11223
Ilina Yelena MD - Brooklyn, NY 11223
Gordin Inna MD - Brooklyn, NY 11223
Polizos Polizos Md - Brooklyn, NY 11223
|
The company N Y Glaucoma Institute provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for N Y Glaucoma Institute, and the business now earns $100.000 to $499.999 per annum.
N Y Glaucoma Institute was launched in 2005 and is classified under SIC code and category , and NAICS number and grouping .
To contact N Y Glaucoma Institute, please call Igor Pankov with the phone number (718) 645-2201 or visit its single location at 103 Quentin Rd.
G1-1 in Brooklyn, New York 11223.
The location of the single location can also be found using the coordinates 40.60436,-73.97383.
Read more details about this business on the webpage glaucomany.com or follow the company’s social media accounts, on Twitter and on Facebook.